New Long-Acting HIV Drug in Zimbabwe Highlights Global Health Challenges We Can’t Ignore
Zimbabwe’s rollout of the new HIV prevention drug lenacapavir offers hope but exposes deeper failures in global health funding and infrastructure—issues with direct impact on America’s strategic and humanitarian interests.
By Economics Desk | February 22, 2026